男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影

HK-Shenzhen pulls off a first under medical connect

By Chai Hua | HK EDITION | Updated: 2021-05-21 14:26
Share
Share - WeChat
Management teams from the University of Hong Kong-Shenzhen Hospital and China Resources Guangdong Pharmaceutical pose for a group photo with the first imported medicine and medical device under the connect on April 16. [Photo provided to China Daily]

Moreover, he said the new channel can expand sales of medical companies. The hospital is purchasing a further 10 titanium rods. Each patient needs only one or two rods.

Lo said safety concerns will ensure the quantity won't be extremely large initially. "The titanium rod producer has agreed to provide the equipment on the mainland because they knew Professor Cheung would perform the surgery," he added, stressing the result of each case is important for the drug and medical equipment producers.

According to HKU-SZH, four other innovative medications have been approved and will soon be put into pilot use at the hospital, following the first drug and device applications.

The first imported medicine under the connect program is Rho(D) immune globulin - a blood disease drug that was used clinically at the hospital on April 29. In addition, the clinical data collected from these applications could also help expedite national approval for related international drugs or devices.

The marketing of many medicines in Hong Kong is synchronized with the world because of mutual recognition, but the mainland needs to do its own clinical results for review and approval, said Huo Peiqiong, general manager of China Resources Guangdong Pharmaceutical - the import agent for the first drugs and equipment.

So registering in Hong Kong or launching the products in the Hong Kong market is much faster than on the mainland, she noted. For example, one drug can be listed in Hong Kong simultaneously in the United States or the United Kingdom.

The connect gives the green light for medicines that are already available in Hong Kong and Macao markets, so more international pharmaceutical enterprises would seek registration there because entering the two special administrative regions mean they could tap the Greater Bay Area or the entire mainland market sooner.

However, it wasn't plain sailing for reviewing, purchasing and transporting the first batch of drugs and device through the connect. Huo recalled it took more than two months to have them delivered.

Many innovative measures were needed to lay a solid foundation for the potential expansion of the connect to more mainland cities. But in the absence of national approval, the import agent had to communicate back and forth between local evaluation authorities and pharmaceutical enterprises to provide proper materials for review.

|<< Previous 1 2 3 4 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 兴隆县| 桐城市| 璧山县| 曲松县| 瑞丽市| 弥勒县| 万载县| 土默特右旗| 綦江县| 唐海县| 怀化市| 岳池县| 蒙阴县| 蒙山县| 平乐县| 明水县| 和平县| 安吉县| 马边| 紫阳县| 德州市| 买车| 临沧市| 壤塘县| 调兵山市| 绵竹市| 新野县| 钟山县| 馆陶县| 长乐市| 钦州市| 永仁县| 新兴县| 玛多县| 汶川县| 驻马店市| 大英县| 吉林省| 扶余县| 云浮市| 太和县| 永昌县| 安溪县| 黔南| 汝阳县| 娱乐| 康平县| 永寿县| 澎湖县| 江阴市| 连州市| 宁蒗| 卓尼县| 博罗县| 南充市| 时尚| 沿河| 和田县| 陆河县| 长岛县| 陵川县| 漯河市| 徐水县| 桑日县| 准格尔旗| 大同县| 嘉黎县| 林甸县| 滕州市| 策勒县| 襄汾县| 松江区| 太康县| 佛冈县| 东兰县| 平邑县| 杭州市| 兰坪| 耒阳市| 温宿县| 湖北省| 雅安市|